Electronic Cigarettes a summary of the current evidence Hayden McRobbie Clinical Director – The Dragon Institute for Innovation Professor of Public Health.

Slides:



Advertisements
Similar presentations
Should Medical Providers Recommend E-cigarettes to their Patients as a Smoking Cessation Tool? There is not yet enough Evidence to Recommend EC as a Primary.
Advertisements

New Tobacco Products: Harm Reduction or Harm Induction? Herbert H. Severson Senior Research Scientist Oregon Research Institute Eugene, Oregon.
E-cigarette use in England: Latest trends from the Smoking Toolkit Study Dr Jamie Brown University College London Dr Emma Beard, Dr Daniel Kotz, Prof Susan.
First vs. Second Generation E- Cigarettes: Predictors of choice and effects on tobacco craving and withdrawal symptoms Dr. Lynne Dawkins Drugs and Addictive.
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
Menthol and Tobacco Regulation
Information on tobacco packages could encourage and help tobacco users to stop using tobacco or find least possible harmful ways of use for those unable.
Vaping profiles and preferences: an online survey of electronic cigarette users Dawkins, L., Turner, J. Roberts, A. & Soar, K. Drugs & Addictive Behaviours.
TOBACCO. Today What is in tobacco that is addictive? Why is tobacco bad for you? What are the BAD parts in smoking? What does it feel like to be a smoker?
Prevention strategies
E-cigarettes The future of smoking?
Unit 21 More on Smoking
Smoking Cessation Its place in Tobacco Control
Kenneth E. Warner University of Michigan University of Iowa November 15, 2002 Technology, Policy, and the Future of Nicotine Addiction.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
Evidence-based/Best Practices Tobacco Control Hadii Mamudu, PhD, MPA COPH-China Institute November 17, 2011.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
Tobacco harm reduction: NICE guidance and recent developments Linda Bauld.
Pacific Nurse Leader and Smoking Cessation Fono
 2011 Johns Hopkins Bloomberg School of Public Health Jonathan M. Samet, MD, MS Director, USC Institute for Global Health Professor and Flora L. Thornton.
Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies Lars M. Ramström Institute for Tobacco.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
E-cigarettes and young people: the evidence so far.
Norris Cotton Cancer CenterJames Sargent MD Professor of Pediatrics Geisel School of Medicine at Dartmouth James Sargent MD Professor of Pediatrics Geisel.
Early interest focused on pseudo-cigarettes. Why? Fascination with high-tech products First “splash” (Premier, mid-1980s) Promised large decreases in a.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
The e-cigarette: opportunity or threat? SSA Annual Symposium 2015 Deborah Arnott Chief Executive Action on Smoking and Health.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
FDA Regulation of Tobacco Washington, DC October 21, 2015 What is Relative Risk-a look at the Continuum of Harm Aruni Bhatnagar, PhD, Professor, University.
* An e-cigarette is a battery-powered device that converts liquid nicotine into a mist, or vapour, that the user inhales. * There's no fire, no ash and.
The Newfoundland and Labrador Alliance for the Control of Tobacco (ACT) and the Non-Smokers’ Rights Association/Smoking and Health Action Foundation Presenter:
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
Better Lung Health For All British Thoracic Society Tobacco Specialist Advisory Group January 2016 Electronic cigarettes.
Electronic cigarette use for quitting smoking in England: 2015 Robert West Jamie Brown University College London
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
1 Access to and use of aids to smoking cessation in the UK Robert West University College London Austin, Texas February 2007.
1 Behaviour change in theory and in real life Robert West University College London Stockholm, April 2008.
1 Recent studies of clinical significance University College London June 2011 Robert West.
1 Impact of the ‘smoking ban’ on smoking prevalence in England Cancer Research UK Health Behaviour Research Centre Department of Epidemiology and Public.
Caroline O. Cobb, Ph.D. VCU Psychology Department & Center for the Study of Tobacco Products Vaping & Students: Who’s Puffing What?
E-Cigarettes: What’s the Real Medical Innovation Breakthrough? Dr Sudhanshu Patwardhan, MBBS, MS, MBA Senior International Engagement Manager, Nicoventures.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
1 Advising smokers on optimum pharmacotherapy for smoking cessation University College London April 2014 Robert West.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
E - CIGARETTES: WHAT’S THE REAL MEDICAL INNOVATION BREAKTHROUGH? Dr Kevin Bridgman - Chief Medical Officer & Director Nicovations is a wholly owned subsidiary.
West Sussex Stop Smoking Service E-Cig Friendly Rebecca Robb and Caroline Staddon, Smokefree West Sussex.
Hot topics in smoking cessation Robert West University College robertjwest 1.
E-cigarettes for lung cancer patients
Electronic Cigarettes: An Opportunity or a Threat to Health? Chris Bullen MBChB, MPH, PhD Charles R Drew University of Medicine and Science 11 th Drug.
Charles Gardner, MD, CCFP, MHSc, FRCPC Medical Officer of Health Simcoe Muskoka District Health Unit October, 2016.
Smoking Cessation Medication
Electronic cigarettes: A new era for tobacco harm reduction Russ Moody Health & Wellbeing Programme Lead Public Health England South West 21st.
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Trends in electronic cigarette use in England
Wireless Access SSID: cwag2017
Quick facts about E-cigarettes for mental health and addiction clinicians and administrators Associate Professor of Psychiatry,
Smoking and smoking cessation in the real world
Use of electronic cigarettes among young people
Electronic Cigarettes – What nurses need to know
Griffith Health Institute
Smoking cessation Felix K. Karthik.
Trends in electronic cigarette use in England
ELECTRONIC CIGARETTES WHAT’S THE BOTTOM LINE?
VAPING AS AN ALTERNATIVE TO TOBACCO SMOKING RELAPSE
E-cigarettes for tobacco harm reduction
Trends in electronic cigarette use in England
Trends in electronic cigarette use in England
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
Presentation transcript:

Electronic Cigarettes a summary of the current evidence Hayden McRobbie Clinical Director – The Dragon Institute for Innovation Professor of Public Health Interventions – Wolfson Institute of Preventive Medicine, Queen Mary University of London

In the past 5 years have received honoraria for speaking at smoking cessation meetings that have been organized by J&J and Pfizer I believe that electronic cigarettes have a role to play in helping people to stop smoking Disclosure

A question for you The long-term use of non-combustible nicotine (as in e-cigarettes) is an acceptable, if not ideal, alternative to continued cigarette smoking. A.Strongly agree B.Somewhat agree C.Neither agree or disagree D.Somewhat disagree E.Strongly disagree

Across the Atlantic At the Global Tobacco Dependence Treatment Summit only 33% of attendees agreed Clive Bates. Are they nuts? The dysfunction and decadence of tobacco control in one chart. 24 May

Rule Britannia

EC use in Great Britain ASH Fact Sheet on the use of electronic cigarettes among adults in Great Britain, May 2016

Nicotine delivery Early studies showed EC available at the time (2007) delivered very little nicotine Newer devices, in the hands of experienced users, can deliver nicotine in a similar way to cigarettes St Helen et al Addiction Oct 2. doi: /add [Epub ahead of print]Addiction.

Device is important Nicotine delivery is generally better from newer (e.g. 2 nd & 3 rd ) generation devices Source: RCP Tobacco Harm Reduction adapted from Farsalinos et al. Scientific Reports 2014;4:4133

Practice is probably important N=6 EC naïve smokers Provided pharmacokinetic data after their first use (5 mins) of EC and again following 4 weeks of use 79% increase in overall nicotine intake –AUC 0→inf increased from 115 to 206 ng*min/ml; p <.05 Hajek et al Nicotine Tob Res 2015;17:175–9.

Do EC help people quit? E-cigarettes show efficacy when used by smokers as an aid to quitting smoking. StudyNicotine ECPlacebo ECRR (95% CI) Bullen 20137% (21/289) 4% (3/73) 1.77 (0.54 – 5.77) Caponnetto % (22/200) 4% (4/100) 2.75 (0.97 – 7.76) Total9% (43/489) 4% (7/173) 2.29 (1.05 – 4.96) StudyNicotine ECNicotine PatchRR (95% CI) Bullen 20137% (21/289) 6% (17/295) 1.26 (0.68 – 2.34) McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD

EC for stopping smoking E-cigarettes are proving much more popular than NRT as a substitute for tobacco cigarettes.

Estimated population impact million 3.16 million Smokers Made a quit attempt 37.3% 0.89 million Used EC 28.2% 22,000 Quit 2.5% West et al. Addiction Jun;111(6):1118-9Addiction. According to the Smoking Toolkit Study, some 0.56 million EC users have stopped smoking so far.

The opposing view Kalkhoran & Glantz. Lancet Respir Med Feb;4(2):116-28

Toxicants in EC vapour Toxicants including acrolein and acetaldehyde, metal and silicate particles, and tobacco-specific nitrosamines (TSNAs) have been found in vapour In general these are at much lower levels than in cigarette smoke

Formaldehyde PowerFormaldehyde (μg/10 puffs) n = 3 Atomiser 1Atomiser watts watts6.1ND 9 watts* watts* Formaldehyde (and other aldehydes) –High levels can be generated when e- cigarettes are operated at high temperatures –Users notice this as an unpleasant taste (known as a ‘dry puff’) and avoid it Atomiser 1 had a double wick, resulting in high liquid supply and lower chance of overheating at high power levels Atomiser 2 was a conventional setup (single wick). *Dry puff conditions Farsalinos et al. Addiction 2015;110:1352–6.

Cardiovascular system No adverse effects of short- term e-cigarette use have been found Some anti-vaping advocates pick up on particle size in EC vapour, but it’s not just size that matters but what they are made of Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP, 2016

Respiratory system EC vapour may have an irritant effect on the airways However, smokers who switch to an e-cigarette are likely to experience improvements in respiratory symptoms Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP, 2016

Flavours Flavours are important to vapers No study so far shows any clear hazards of flavours in e-cigarette vapour, but some may yet emerge

Level of risk We cannot be certain on the exact degree of risk However, an estimate can be based on the facts that the constituents of cigarette smoke that harm health are either –absent in e-cigarette vapour, or –if present, are mostly at levels significantly below 5% of doses from smoking (mostly below 1%) At least 95 % Safer Nutt et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014;20:218–25. McNeill et al. E-cigarettes: an evidence update. A report commissioned by Public Health England. London: PHE, 2015.

Perception of harm is going the wrong way ASH Fact Sheet on the use of electronic cigarettes among adults in Great Britain, May 2016

Perceptions of nicotine ASH Fact Sheet on the use of electronic cigarettes among adults in Great Britain, May 2016

Lower addiction potential than cigarettes Very few never smokers who try EC become regular users EC users report that they feel less dependent on them than on cigarettes Possible reasons for this include: –pulmonary absorption from currently available EC is likely to be low, especially with first time use –The addictiveness of cigarettes is likely to also be related to other substances in tobacco smoke This may change in the future as EC technology evolves

Other Concerns? That e-cigarettes will: –renormalising the act of smoking –acting as a gateway to smoking in young people –being used for temporary, not permanent, abstinence from smoking

Dual use Around two-thirds of EC users also smoke Concern that dual use might –Expose users to increased toxins –People may not stop smoking conventional cigarettes Brose et al. Addiction 2015;110:1160–8; Hitchman et al. Nicotine Tob Res 2015;17:1187–94

Reduction in acrolein exposure p<0.001 McRobbie et al. Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein. Cancer Prev. Res , 873–878

Tobacco control & regulation Smoked tobacco is the most harmful form of tobacco use Nicotine use is associated very few adverse health risks

Policy and public health Policies should aim to: –Discourage EC use by non-smokers who would not have smoked otherwise –Encourage innovations in EC that promote smoking cessation

Making sense of the evidence

Conclusions There is growing evidence that electronic cigarettes can help people stop smoking Long-term health effects are unknown, however any risks are likely to be many times less than risks associated with smoking tobacco Unnecessary regulation will threaten potential benefits Ongoing monitoring is needed to assess emerging problems and benefits

THE END